These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6047753)

  • 1. A new repository antimalarial agent, CI-564, used in a field trial in New Guinea.
    Rieckmann KH
    Trans R Soc Trop Med Hyg; 1967; 61(2):189-98. PubMed ID: 6047753
    [No Abstract]   [Full Text] [Related]  

  • 2. Field trials of repository antimalarial compounds.
    Clyde DF
    J Trop Med Hyg; 1969 Apr; 72(4):81-5. PubMed ID: 4890149
    [No Abstract]   [Full Text] [Related]  

  • 3. A trial of CI-564 (dapolar), a repository antimalarial for prophylaxis in Amapá, Brazil.
    Gusmão HH; Juarez E
    Am J Trop Med Hyg; 1970 May; 19(3):394-400. PubMed ID: 4911012
    [No Abstract]   [Full Text] [Related]  

  • 4. The suppression of malaria with dapolar: a trial of 4-monthly doses in a village community in the Gambia, West Africa.
    Laing AB
    Trans R Soc Trop Med Hyg; 1971; 65(5):560-73. PubMed ID: 4945932
    [No Abstract]   [Full Text] [Related]  

  • 5. A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea.
    Rieckmann KH
    Am J Trop Med Hyg; 1966 Nov; 15(6):833-7. PubMed ID: 5335161
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of cutaneous leishmaniasis (oriental sore) with a new repository antimalarial.
    Kurban AK; Malak JA; Farah FS; Siage J; Jallad M
    J Trop Med Hyg; 1969 Apr; 72(4):86-8. PubMed ID: 5769717
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on depot antimalarials. I. The effect of a single injection of the depot antimalarial CI-501 ("Camolar") on relapsing vivax malaria acquired in New Guinea.
    Black RH; Dew BB; Hennessy WB; McMillan B; Torpy DC
    Med J Aust; 1966 Sep; 2(13):588-92. PubMed ID: 5921546
    [No Abstract]   [Full Text] [Related]  

  • 8. Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents.
    Elslager EF; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):363-7. PubMed ID: 4977944
    [No Abstract]   [Full Text] [Related]  

  • 9. Respository drugs. IV. 4',4'''-Sulfonylbisacetanilide (Acedapsone, DADDS) and related sulfanilylanilides with prolonged antimalarial and antileprotic action.
    Elslager EF; Gavrilis ZB; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):357-63. PubMed ID: 4892242
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the antimalarial activity of dihydrotriazine pamoate C. I. Camolar].
    Payet M; Pène P; Michel R; Sankalé M; Bernou JC; Guèye I
    Bull Soc Med Afr Noire Lang Fr; 1966; 11(2):147-69. PubMed ID: 5914183
    [No Abstract]   [Full Text] [Related]  

  • 11. Some haematological and biochemical effects of a malaria control programme in New Guinea.
    MacLennan R; Walsh RJ
    Hum Biol Oceania; 1973 Feb; 2(1):33-41. PubMed ID: 4575551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malaria prevention].
    Bygbjerg I; Fogh S; Olsen VV; Black F; Effersøe P; Jepsen S
    Ugeskr Laeger; 1983 Jan; 145(4):262-4. PubMed ID: 6342246
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations on the effect of malanidinum injection in the treatment of malaria].
    Xu YX
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):686-8. PubMed ID: 6819882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malaria prevention--suggestions for recommendations].
    Rombo L; Andersson T; Bengtsson E; Björkman A; Britton S; Hellgren U; Lundbergh P; Tideström L; Brohult J; Stenbeck J
    Lakartidningen; 1986 Jun; 83(26-27):2375-80. PubMed ID: 3736283
    [No Abstract]   [Full Text] [Related]  

  • 15. Malaria treatment and prevention. A review.
    Hall SA
    East Afr Med J; 1969 Oct; 46(10):553-63. PubMed ID: 4905723
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the antimalarial activity of dihydrotriazine pamoate (Camolar) associated with Camoquin].
    Pène P; Michel R; Bernou JC; Gueye
    Bull Soc Pathol Exot Filiales; 1968; 61(3):413-24. PubMed ID: 5756589
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
    Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial studies on 4,4-diaminodiphenyl sulfone (DDS) and repository sulfones in experimental animals.
    Thompson PE
    Int J Lepr Other Mycobact Dis; 1967; 35(4):605-15. PubMed ID: 5626306
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of malaria in Tanzania with the use of medicated salt.
    Clyde DF
    Bull World Health Organ; 1966; 35(6):962-8. PubMed ID: 5298044
    [No Abstract]   [Full Text] [Related]  

  • 20. Field trial of cycloguanil pamoate in the treatment and suppression of malaria in Nigerian school children: a preliminary report.
    Fasan PO
    Trans R Soc Trop Med Hyg; 1970; 64(6):839-49. PubMed ID: 5495634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.